Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Miloš Duka

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

Mediators of Inflammation

Immunology

Cell Biology

2019

English

Related publications

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

Przeglad Gastroenterologiczny

Gastroenterology

2011

English

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

Journal of Investigative Dermatology

English

SERUM LEVELS OF SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR- KAPPA-B Ligand (S-Rankl) IN PATIENTS WITH DIFUSSE IDIOPATHIC SKELETAL HYPEROSTOSIS AND ANKILOSING SPONDILITIS

Knowledge International Journal

2018

English

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages

Experimental Dermatology

English

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts

Experimental and Therapeutic Medicine

English

Strontium Ranelate Reduces the Progression of Titanium Particle-Induced Osteolysis by Increasing the Ratio of Osteoprotegerin to Receptor Activator of Nuclear Factor-κB Ligand Inï¿½vivo

Molecular Medicine Reports

English

141 Soluble Receptor Activator of Nuclear Factor Κ B Ligand (S RANK-L) Levels in Paediatric Onset SLE

2017

English

Investigating the Interaction Between Osteoprotegerin and Receptor Activator of NF-κB or Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

Journal of Biological Chemistry

English

Marginal Jawbone Loss Is Associated With Onset of Rheumatoid Arthritis and Is Related to Plasma Level of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)

Arthritis and Rheumatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Miloš Duka

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

Related publications

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

SERUM LEVELS OF SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR- KAPPA-B Ligand (S-Rankl) IN PATIENTS WITH DIFUSSE IDIOPATHIC SKELETAL HYPEROSTOSIS AND ANKILOSING SPONDILITIS

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts

Strontium Ranelate Reduces the Progression of Titanium Particle-Induced Osteolysis by Increasing the Ratio of Osteoprotegerin to Receptor Activator of Nuclear Factor-κB Ligand Inï¿½vivo

141 Soluble Receptor Activator of Nuclear Factor Κ B Ligand (S RANK-L) Levels in Paediatric Onset SLE

Investigating the Interaction Between Osteoprotegerin and Receptor Activator of NF-κB or Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

Marginal Jawbone Loss Is Associated With Onset of Rheumatoid Arthritis and Is Related to Plasma Level of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)